190 related articles for article (PubMed ID: 8421596)
21. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
[TBL] [Abstract][Full Text] [Related]
22. Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms.
Queen WD; Bharwani N; Phillips EA; Ruether BA; Phillips TM; Jerry LM
Oncology; 1989; 46(1):14-25. PubMed ID: 2915889
[TBL] [Abstract][Full Text] [Related]
23. Circulating immune complexes in human malignant melanoma.
D'Amelio R; Cooke B; Hobbs JR
Tumori; 1982 Dec; 68(6):469-72. PubMed ID: 7168010
[TBL] [Abstract][Full Text] [Related]
24. Detection of rheumatoid factors of different isotypes and of circulating immune complexes in patients with inflammatory bowel disease.
Procaccia S; Bianchi Porro G; Colucci A; Villa P; Blasio R; Ardizzone S; Bonacina CA; Zanussi C
Boll Ist Sieroter Milan; 1990 Jun; 69(2):413-21. PubMed ID: 2152301
[TBL] [Abstract][Full Text] [Related]
25. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
Araki K; Tsuji T; Onoue K; Tsuchiya M; Shinohara T; Inoue J; Nagashima H
Acta Med Okayama; 1980 Mar; 34(2):131-8. PubMed ID: 6450515
[TBL] [Abstract][Full Text] [Related]
26. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
Araki K; Nagashima H; Tsuji T
Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
[TBL] [Abstract][Full Text] [Related]
27. Circulating immune complexes in Hodgkin's disease.
Akolkar PN; Advani SH; Gothoskar BP
Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
[TBL] [Abstract][Full Text] [Related]
28. [TA90--new neoplastic marker].
Rudzki S; Gołyski J; Bronikowski P; Gołyska D
Pol Merkur Lekarski; 2010 Mar; 28(165):211-3. PubMed ID: 20815170
[TBL] [Abstract][Full Text] [Related]
29. Analysis of circulating immune complexes from patients with ankylosing spondylitis by gel electrophoresis and immunoblotting using antiserum against a psoriasis associated retrovirus-like particle.
Rødahl E; Iversen OJ
Ann Rheum Dis; 1986 Nov; 45(11):892-8. PubMed ID: 3539036
[TBL] [Abstract][Full Text] [Related]
30. The presence and structure of circulating immune complexes in patients with prostate tumors.
Gołda R; Wolski Z; Wyszomirska-Gołda M; Madaliński K; Michałkiewicz J
Med Sci Monit; 2004 Mar; 10(3):CR123-7. PubMed ID: 14976452
[TBL] [Abstract][Full Text] [Related]
31. Relationship between circulating immune complexes and urinary antigens in human malignancy.
Huth JF; Gupta RK; Morton DL
Cancer; 1982 Mar; 49(6):1150-7. PubMed ID: 7037157
[TBL] [Abstract][Full Text] [Related]
32. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
[TBL] [Abstract][Full Text] [Related]
33. Circulating Clq binding complexes in inflammatory bowel diseases.
Einstein E; Charland C; Thayer WR
Digestion; 1979; 19(1):65-9. PubMed ID: 456771
[TBL] [Abstract][Full Text] [Related]
34. TA90 immune complex predicts survival following surgery and adjuvant vaccine immunotherapy for stage IV melanoma.
Hsueh EC; Gupta RK; Qi K; Yee R; Leopoldo ZC; Morton DL
Cancer J Sci Am; 1997; 3(6):364-70. PubMed ID: 9403050
[TBL] [Abstract][Full Text] [Related]
35. Detection of mycobacterial antigen in circulating immune complexes in patients with childhood tuberculosis.
Srivastava L; Srivastava VK
Indian J Pathol Microbiol; 1999 Oct; 42(4):405-9. PubMed ID: 11127369
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of cell-mediated immunity and circulating immune complexes as prognostic indicators in cancer patients.
Aziz M; Akhtar S; Malik A
Cancer Detect Prev; 1998; 22(2):87-99. PubMed ID: 9544429
[TBL] [Abstract][Full Text] [Related]
37. Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients.
Wong JH; Aguero B; Gupta RK; Morton DL
Cancer Immunol Immunother; 1988; 27(2):142-6. PubMed ID: 3046746
[TBL] [Abstract][Full Text] [Related]
38. The nature of immune complexes in human cancer sera.
Theofilopoulos AN; Andrews BS; Urist MM; Morton DL; Dixon FJ
J Immunol; 1977 Aug; 119(2):657-63. PubMed ID: 886189
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of circulating immune complexes and serum immunoglobulins in oral cancer patients--a follow up study.
Parveen S; Taneja N; Bathi RJ; Deka AC
Indian J Dent Res; 2010; 21(1):10-5. PubMed ID: 20427899
[TBL] [Abstract][Full Text] [Related]
40. [Progressive increase of serum circulating immune complexes and its significance in patients during the progression from chronic hepatitis B to hepatocellular carcinoma].
Du J; Tian P; Chen TY; Wu JX; Wang JB; Wei Y; Wang LM; Liu LG; Ji WS; Qu CF
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):905-10. PubMed ID: 22340099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
